Spiro-oxindole MDM2 antagonists
    6.
    发明授权
    Spiro-oxindole MDM2 antagonists 有权
    螺羟吲哚MDM2拮抗剂

    公开(公告)号:US08680132B2

    公开(公告)日:2014-03-25

    申请号:US13294315

    申请日:2011-11-11

    CPC classification number: A61N5/10 A61K31/407 A61K45/06 C07D487/10 A61K2300/00

    Abstract: Provided herein are compounds, compositions, and methods in the field of medicinal chemistry. The compounds and compositions provided herein relate to spiro-oxindoles which function as antagonists of the interaction between p53 and MDM2, and their use as therapeutics for the treatment of cancer and other diseases.

    Abstract translation: 本文提供了药物化学领域中的化合物,组合物和方法。 本文提供的化合物和组合物涉及用作p53和MDM2之间相互作用的拮抗剂的螺 - 羟基吲哚,以及它们作为治疗癌症和其它疾病的治疗剂的用途。

Patent Agency Ranking